Potentiation of TNF-alpha toxicity by conjugation with ricin A-chain.

Potentiation of TNF-alpha toxicity by conjugation with ricin A-chain.

Hybrid toxins containing a cytokine moiety have been used effectively to selectively kill cells expressing the complementary cytokine receptor both in vivo and in vitro. To date all cytokines incorporated into hybrid toxins, e.g. interleukin 2 are biologically active as monomers, so attachment of a...

Bibliografske podrobnosti
Main Authors:	Gould, D, Foxwell, B, Feldmann, M, Chernajovsky, Y
Format:	Journal article
Jezik:	English
Izdano:	1998

Podobne knjige/članki

The role of TNF alpha and IL-1 in rheumatoid arthritis.
od: Feldmann, M, et al.
Izdano: (2001)

Interleukin-4 inhibits kappa light chain expression and NF kappa B activation but not I kappa B alpha degradation in 70Z/3 murine pre-B cells.
od: Clarke, C, et al.
Izdano: (1995)

Tumor necrosis factor-alpha (TNF) triggers a cytokine cascade yielding postoperative cognitive decline
od: Terrando, N, et al.
Izdano: (2010)

Comparative Aspects of Ricin Toxicity by Inhalation
od: Alexander Stoll, et al.
Izdano: (2023-04-01)

Ricin Toxicity: Clinical and Molecular Aspects
od: Mohammad Moshiri, et al.
Izdano: (2016-05-01)

Advanced glycation end products (AGEs) augment production of vascular endothelial growth factor (VEGF) and tumor necrosis factor alpha (TNF alpha) in human monocyte-derived macrophages.
od: Pertynska-Marczewska, M, et al.
Izdano: (2003)

Toxicity of ricin present in castor bean seeds
od: Nayanna Brunna da Silva Fonseca, et al.
Izdano: (2014-06-01)

The murine p75 TNF receptor promoter region: DNA sequence and characterization of a cis-acting silencer.
od: Kissonerghis, M, et al.
Izdano: (1999)

Toxicity and Efficacy Evaluation of Soluble Recombinant Ricin Vaccine
od: Hyeongseok Yun, et al.
Izdano: (2024-09-01)

TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.
od: Maini, R, et al.
Izdano: (1993)

Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-alpha: role of the p38 and p42/44 mitogen-activated protein kinases.
od: Foey, A, et al.
Izdano: (1998)

RelB/p50 regulates TNF production in LPS-stimulated dendritic cells and macrophages.
od: Gasparini, C, et al.
Izdano: (2013)

RelB/p50 regulates TNF production in LPS-stimulated dendritic cells and macrophages
od: Gasparini, C, et al.
Izdano: (2013)

TNF receptor fusion proteins are effective inhibitors of TNF-mediated cytotoxicity on human KYM-1D4 rhabdomyosarcoma cells.
od: Butler, D, et al.
Izdano: (1994)

TNF alpha--a pivotal role in rheumatoid arthritis?
od: Brennan, F, et al.
Izdano: (1992)

Targeting TNF alpha for the therapy of rheumatoid arthritis.
od: Maini, R, et al.
Izdano: (1994)

The cytokine network in rheumatoid arthritis: definition of TNF alpha as a therapeutic target.
od: Feldmann, M
Izdano: (1996)

Ricin Antibodies’ Neutralizing Capacity against Different Ricin Isoforms and Cultivars
od: Maria Lucia Orsini Delgado, et al.
Izdano: (2021-01-01)

Structural Re-Alignment in an Immunogenic Surface Region of Ricin a Chain
od: Adam T. Zemla, et al.
Izdano: (2008-01-01)

Structural Re-Alignment in an Immunogenic Surface Region of Ricin A Chain
od: Adam T. Zemla, et al.
Izdano: (2008-02-01)

Structural Re-Alignment in an Immunogenic Surface Region of Ricin A Chain
od: Adam T. Zemla, et al.
Izdano: (2008-01-01)

TNF alpha as a therapeutic target in rheumatoid arthritis.
od: Feldmann, M, et al.
Izdano: (1994)

STRUCTURE-FUNCTION STUDIES ON THE EXTRACELLULAR DOMAIN OF THE HUMAN P55 TNF RECEPTOR
od: Corcoran, A, et al.
Izdano: (1992)

Gene therapy for chronic relapsing experimental allergic encephalomyelitis using cells expressing a novel soluble p75 dimeric TNF receptor.
od: Croxford, J, et al.
Izdano: (2000)

Ricin Trafficking in Cells
od: Robert A. Spooner, et al.
Izdano: (2015-01-01)

First Ricin Readings
od: Oleksandr N. Sagan
Izdano: (1998-12-01)

Diverse Profiles of Ricin-Cell Interactions in the Lung Following Intranasal Exposure to Ricin
od: Anita Sapoznikov, et al.
Izdano: (2015-11-01)

Ricin and Ricin-Containing Immunotoxins: Insights into Intracellular Transport and Mechanism of action in Vitro
od: Monika Słomińska-Wojewódzka, et al.
Izdano: (2013-04-01)

TNF alpha is an effective therapeutic target for rheumatoid arthritis.
od: Feldmann, M, et al.
Izdano: (1995)

Evaluation of TNF-alpha and IL-1 blockade in collagen-induced arthritis and comparison with combined anti-TNF-alpha/anti-CD4 therapy.
od: Williams, R, et al.
Izdano: (2000)

A novel mechanism for TNF-alpha regulation by p38 MAPK: involvement of NF-kappa B with implications for therapy in rheumatoid arthritis.
od: Campbell, J, et al.
Izdano: (2004)

Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)
od: Maini, R, et al.
Izdano: (1995)

Anti-TNF therapy: where have we got to in 2005?
od: Feldmann, M, et al.
Izdano: (2005)

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
od: Feldmann, M, et al.
Izdano: (2001)

Establishment of a Novel Oral Murine Model of Ricin Intoxication and Efficacy Assessment of Ovine Ricin Antitoxins
od: Sarah J. Whitfield, et al.
Izdano: (2020-12-01)

Discovery of TNF-alpha as a therapeutic target in rheumatoid arthritis: preclinical and clinical studies.
od: Feldmann, M, et al.
Izdano: (2002)

Mannosidase 2, alpha 1 deficiency is associated with ricin resistance in embryonic stem (ES) cells.
od: Wei Wang, et al.
Izdano: (2011-01-01)

How Ricin Damages the Ribosome
od: Przemysław Grela, et al.
Izdano: (2019-04-01)

Inhibitors of the Cellular Trafficking of Ricin
od: Daniel Gillet, et al.
Izdano: (2012-01-01)

Therapeutic antibodies elicited by immunization against TNF-alpha.
od: Dalum, I, et al.
Izdano: (1999)